149 related articles for article (PubMed ID: 10727849)
1. Abnormal phenotype of in vitro dermal fibroblasts from patients with Pseudoxanthoma elasticum (PXE).
Quaglino D; Boraldi F; Barbieri D; Croce A; Tiozzo R; Pasquali Ronchetti I
Biochim Biophys Acta; 2000 Apr; 1501(1):51-62. PubMed ID: 10727849
[TBL] [Abstract][Full Text] [Related]
2. Cell-matrix interactions in cultured dermal fibroblasts from patients with an inherited connective-tissue disorder.
Baccarani Contri M; Tiozzo R; Croce MA; Andreoli T; De Paepe A
Cytotechnology; 1993; 11 Suppl 1():S112-4. PubMed ID: 7763736
[TBL] [Abstract][Full Text] [Related]
3. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D
J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773
[TBL] [Abstract][Full Text] [Related]
4. Pseudoxanthoma elasticum (PXE): ultrastructural and biochemical study on proteoglycan and proteoglycan-associated material produced by skin fibroblasts in vitro.
Tiozzo Costa R; Baccarani Contri M; Cingi MR; Pasquali Ronchetti I; Salvini R; Rindi S; De Luca G
Coll Relat Res; 1988 Jan; 8(1):49-64. PubMed ID: 3345648
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli.
Boraldi F; Annovi G; Bartolomeo A; Quaglino D
J Dermatol Sci; 2014 Apr; 74(1):72-80. PubMed ID: 24461675
[TBL] [Abstract][Full Text] [Related]
6. Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential.
Quaglino D; Sartor L; Garbisa S; Boraldi F; Croce A; Passi A; De Luca G; Tiozzo R; Pasquali-Ronchetti I
Biochim Biophys Acta; 2005 Jun; 1741(1-2):42-7. PubMed ID: 15955448
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis.
Hendig D; Langmann T; Kocken S; Zarbock R; Szliska C; Schmitz G; Kleesiek K; Götting C
Lab Invest; 2008 Dec; 88(12):1303-15. PubMed ID: 18936737
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elasticum patients.
Baccarani-Contri M; Vincenzi D; Cicchetti F; Mori G; Pasquali-Ronchetti I
Eur J Histochem; 1994; 38(2):111-23. PubMed ID: 7524808
[TBL] [Abstract][Full Text] [Related]
9. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro.
Le Saux O; Bunda S; VanWart CM; Douet V; Got L; Martin L; Hinek A
J Invest Dermatol; 2006 Jul; 126(7):1497-505. PubMed ID: 16543900
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients.
Boraldi F; Quaglino D; Croce MA; Garcia Fernandez MI; Tiozzo R; Gheduzzi D; Bacchelli B; Pasquali Ronchetti I
Matrix Biol; 2003 Nov; 22(6):491-500. PubMed ID: 14667841
[TBL] [Abstract][Full Text] [Related]
11. Fibrillin immunofluorescence in pseudoxanthoma elasticum.
Godfrey M; Cisler J; Geerts ML; Christiano A; Uitto J; De Bie S; DePaepe A
J Am Acad Dermatol; 1995 Apr; 32(4):589-94. PubMed ID: 7896947
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dermal myofibroblast differentiation in pseudoxanthoma elasticum.
Faust I; Donhauser E; Fischer B; Ibold B; Kuhn J; Knabbe C; Hendig D
Exp Cell Res; 2017 Nov; 360(2):153-162. PubMed ID: 28882457
[TBL] [Abstract][Full Text] [Related]
13. In vitro uptake of calcium by dermis of patients with pseudoxanthoma elasticum.
Gordon SG; Subryan VL; Solomons CC; Lewis BJ; Neldner KH
J Lab Clin Med; 1975 Oct; 86(4):638-43. PubMed ID: 1176814
[TBL] [Abstract][Full Text] [Related]
14. Matrix gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts from PXE patients and controls.
Boraldi F; Annovi G; Vermeer C; Schurgers LJ; Trenti T; Tiozzo R; Guerra D; Quaglino D
J Invest Dermatol; 2013 Apr; 133(4):946-54. PubMed ID: 23223140
[TBL] [Abstract][Full Text] [Related]
15. Identification of heterozygote carriers in families with a recessive form of pseudoxanthoma elasticum (PXE).
Bacchelli B; Quaglino D; Gheduzzi D; Taparelli F; Boraldi F; Trolli B; Le Saux O; Boyd CD; Ronchetti IP
Mod Pathol; 1999 Dec; 12(12):1112-23. PubMed ID: 10619263
[TBL] [Abstract][Full Text] [Related]
16. Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum.
Gheduzzi D; Sammarco R; Quaglino D; Bercovitch L; Terry S; Taylor W; Ronchetti IP
Ultrastruct Pathol; 2003; 27(6):375-84. PubMed ID: 14660276
[TBL] [Abstract][Full Text] [Related]
17. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients.
Gheduzzi D; Boraldi F; Annovi G; DeVincenzi CP; Schurgers LJ; Vermeer C; Quaglino D; Ronchetti IP
Lab Invest; 2007 Oct; 87(10):998-1008. PubMed ID: 17724449
[TBL] [Abstract][Full Text] [Related]
18. Nonlinear optical microscopy is a novel tool for the analysis of cutaneous alterations in pseudoxanthoma elasticum.
Kiss N; Fésűs L; Bozsányi S; Szeri F; Van Gils M; Szabó V; Nagy AI; Hidvégi B; Szipőcs R; Martin L; Vanakker O; Arányi T; Merkely B; Wikonkál NM; Medvecz M
Lasers Med Sci; 2020 Oct; 35(8):1821-1830. PubMed ID: 32372237
[TBL] [Abstract][Full Text] [Related]
19. Linking ABCC6 Deficiency in Primary Human Dermal Fibroblasts of PXE Patients to p21-Mediated Premature Cellular Senescence and the Development of a Proinflammatory Secretory Phenotype.
Tiemann J; Wagner T; Lindenkamp C; Plümers R; Faust I; Knabbe C; Hendig D
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352936
[TBL] [Abstract][Full Text] [Related]
20. Evidence for increased protease activity secreted from cultured fibroblasts from patients with pseudoxanthoma elasticum.
Gordon SG; Overland M; Foley J
Connect Tissue Res; 1978; 6(1):61-8. PubMed ID: 149650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
